Stemonix, Inc, based in Maple Grove, MN, is a leading provider of human-first drug discovery solutions, partnering with biopharma, academic, and government institutions. Their innovative microBrain platform offers ready-to-use multi-well plates containing functional microtissues derived from human induced pluripotent stem cells (iPSC), enabling high-throughput human drug screening and significantly reducing costs and time for their partners.
With consistent cultures of neurons and astrocytes co-differentiated from a single donor source, Stemonix's microBrain platform brings human biology to the bench in both 2D and 3D formats. Their Assay AnalytiX platform provides advanced analysis for more valuable and robust data, helping to accelerate the development of new treatments and get medications to patients faster.
Generated from the website